Lenalidomide is active for extramedullary disease in refractory multiple myeloma

被引：0

作者：

Tomonori Nakazato

Ai Mihara

Chisako Ito

Yukinari Sanada

Yoshinobu Aisa

机构：

[1] Yokohama Municipal Citizen’s Hospital,Department of Hematology

来源：

Annals of Hematology | 2012年 / 91卷

关键词：

Multiple Myeloma; Thalidomide; Bortezomib; Lenalidomide; Bacterial Pneumonia;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：473 / 474

页数：1

共 50 条

[41] Lenalidomide in multiple myeloma: current experimental and clinical data [J].

Cives, Mauro ;

Milano, Annalisa ;

Dammacco, Franco ;

Silvestris, Franco .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 88 (04) :279-291

[42] Lenalidomide in multiple myeloma [J].

Richardson, Paul G. ;

Mitsiades, Constantine ;

Hideshima, Teru ;

Anderson, Kenneth C. .

EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (08) :1165-1173

[43] Lenalidomide in multiple myeloma [J].

Sirohi, Bhawna ;

Powles, Ray .

EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (11) :1559-1570

[44] Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement [J].

M A Dimopoulos ;

A Palumbo ;

M Attal ;

M Beksaç ;

F E Davies ;

M Delforge ;

H Einsele ;

R Hajek ;

J-L Harousseau ;

F Leal da Costa ;

H Ludwig ;

U-H Mellqvist ;

G J Morgan ;

J F San-Miguel ;

S Zweegman ;

P Sonneveld .

Leukemia, 2011, 25 :749-760

[45] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma [J].

D S Siegel ;

P Richardson ;

M Dimopoulos ;

P Moreau ;

C Mitsiades ;

D Weber ;

J Houp ;

C Gause ;

S Vuocolo ;

J Eid ;

T Graef ;

K C Anderson .

Blood Cancer Journal, 2014, 4 :e182-e182

[46] Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma [J].

Palumbo, A. ;

Larocca, A. ;

Falco, P. ;

Sanpaolo, G. ;

Falcone, A. P. ;

Federico, V. ;

Canepa, L. ;

Crugnola, M. ;

Genuardi, M. ;

Magarotto, V. ;

Petrucci, M. T. ;

Boccadoro, M. .

LEUKEMIA, 2010, 24 (05) :1037-1042

[47] Lenalidomide in multiple myeloma [J].

Thomas, Sheeba K. ;

Richards, Tiffany A. ;

Weber, Donna M. .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) :717-735

[48] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma [J].

Munshi, Nikhil C. ;

Mitsiades, Constantine ;

Richardson, Paul G. ;

Anderson, Kenneth C. .

NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (07) :374-375

[49] Bortezomib:: an effective agent in extramedullary disease in multiple myeloma [J].

Laura, R ;

Cibeira, MT ;

Uriburu, C ;

Yantorno, S ;

Salamero, O ;

Bladé, J ;

Montserrat, E .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (05) :405-408

[50] Cytogenetics in multiple myeloma patients progressing into extramedullary disease [J].

Besse, Lenka ;

Sedlarikova, Lenka ;

Greslikova, Henrieta ;

Kupska, Renata ;

Almasi, Martina ;

Penka, Miroslav ;

Jelinek, Tomas ;

Pour, Ludek ;

Adam, Zdenek ;

Kuglik, Petr ;

Krejci, Marta ;

Hajek, Roman ;

Sevcikova, Sabina .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (01) :93-100

← 1 2 3 4 5 →